MendelFOLD

MendelFold develops computational tools that predict protein 3D structure from sequence, including folding trees, structural ensembles and folding energy landscapes, and analyse allosteric communication between residues and pathways.

The company sells its protein analysis services and platform to researchers, pharmaceutical teams and innovators working on drug design and synthetic biology. The website does not describe pricing or a revenue model.

MendelFold was founded in November 2024 as a spin-out of Mendel University in Brno, Czech Republic, and lists Brno as its base. The team includes founders and co-founders with backgrounds in chemistry, biochemistry and structural bioinformatics, and a CEO and a director for customer success and product management.

Product: Protein 3D structure prediction service with folding-ensemble reports, and allosteric analysis of residue-residue networks and information flow.